Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAPT-SFA
2018-000532-94Phase 4Terminated
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Nov 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of aspirin and clopidogrel in peripheral artery occlusion (PAD) and Superficial femoral artery stenosis (2 arms), sponsored by IRCCS San Matteo Foundation. Primary endpoint: Late lumen loss at 12 months. Started Nov 2020; status: terminated.
02
Drugs
aspirinclopidogrel
03
Conditions
peripheral artery occlusion (PAD)Superficial femoral artery stenosis
Beyond the preview
Go deeper on 2018-000532-94.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000532-94.